A detailed history of Barclays PLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Barclays PLC holds 39,308 shares of EBS stock, worth $326,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,308
Previous 39,308 -0.0%
Holding current value
$326,256
Previous $329,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$5.72 - $14.77 $176,130 - $454,797
30,792 Added 361.58%
39,308 $329,000
Q2 2024

Aug 14, 2024

SELL
$1.86 - $6.98 $55,219 - $207,222
-29,688 Reduced 77.71%
8,516 $58,000
Q1 2024

May 15, 2024

SELL
$1.5 - $3.41 $152,086 - $345,743
-101,391 Reduced 72.63%
38,204 $97,000
Q4 2023

Feb 15, 2024

BUY
$1.82 - $3.16 $47,667 - $82,763
26,191 Added 23.1%
139,595 $336,000
Q3 2023

Nov 07, 2023

SELL
$3.17 - $7.91 $538,909 - $1.34 Million
-170,003 Reduced 59.99%
113,404 $385,000
Q2 2023

Aug 03, 2023

BUY
$7.35 - $13.21 $928,937 - $1.67 Million
126,386 Added 80.49%
283,407 $2.08 Million
Q1 2023

May 04, 2023

SELL
$7.79 - $16.29 $634,059 - $1.33 Million
-81,394 Reduced 34.14%
157,021 $1.63 Million
Q4 2022

Feb 13, 2023

BUY
$11.0 - $21.45 $750,475 - $1.46 Million
68,225 Added 40.09%
238,415 $2.82 Million
Q3 2022

Nov 03, 2022

BUY
$20.09 - $35.8 $2.95 Million - $5.26 Million
146,857 Added 629.4%
170,190 $3.57 Million
Q2 2022

Aug 12, 2022

SELL
$27.42 - $43.63 $1.13 Million - $1.8 Million
-41,222 Reduced 63.86%
23,333 $724,000
Q1 2022

May 16, 2022

BUY
$36.48 - $52.22 $24,952 - $35,718
684 Added 1.07%
64,555 $2.65 Million
Q4 2021

Feb 14, 2022

BUY
$33.11 - $55.01 $563,730 - $936,600
17,026 Added 36.35%
63,871 $2.78 Million
Q3 2021

Nov 09, 2021

BUY
$50.07 - $66.05 $141,047 - $186,062
2,817 Added 6.4%
46,845 $2.35 Million
Q2 2021

Aug 13, 2021

SELL
$56.61 - $80.46 $493,922 - $702,013
-8,725 Reduced 16.54%
44,028 $2.77 Million
Q1 2021

May 13, 2021

BUY
$86.23 - $125.19 $998,198 - $1.45 Million
11,576 Added 28.11%
52,753 $4.9 Million
Q4 2020

Feb 11, 2021

SELL
$79.17 - $111.47 $2.1 Million - $2.95 Million
-26,485 Reduced 39.14%
41,177 $3.69 Million
Q3 2020

Nov 12, 2020

SELL
$81.91 - $134.94 $315,926 - $520,463
-3,857 Reduced 5.39%
67,662 $6.99 Million
Q2 2020

Aug 12, 2020

SELL
$54.33 - $89.52 $3.06 Million - $5.04 Million
-56,272 Reduced 44.03%
71,519 $5.66 Million
Q1 2020

May 13, 2020

SELL
$49.34 - $68.76 $2.84 Million - $3.95 Million
-57,468 Reduced 31.02%
127,791 $7.39 Million
Q4 2019

Feb 10, 2020

BUY
$51.21 - $59.06 $6.57 Million - $7.58 Million
128,299 Added 225.24%
185,259 $10 Million
Q3 2019

Nov 14, 2019

SELL
$40.6 - $57.2 $257,322 - $362,533
-6,338 Reduced 10.01%
56,960 $2.98 Million
Q2 2019

Aug 14, 2019

BUY
$39.92 - $53.86 $926,183 - $1.25 Million
23,201 Added 57.86%
63,298 $3.06 Million
Q1 2019

May 15, 2019

BUY
$48.23 - $66.16 $649,851 - $891,439
13,474 Added 50.61%
40,097 $2.03 Million
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $1.11 Million - $1.46 Million
-19,959 Reduced 42.85%
26,623 $1.58 Million
Q3 2018

Nov 14, 2018

BUY
$52.05 - $66.51 $1.72 Million - $2.19 Million
32,973 Added 242.29%
46,582 $3.07 Million
Q2 2018

Aug 14, 2018

SELL
$48.33 - $55.64 $554,248 - $638,079
-11,468 Reduced 45.73%
13,609 $687,000
Q1 2018

May 15, 2018

BUY
$44.44 - $54.39 $116,477 - $142,556
2,621 Added 11.67%
25,077 $1.32 Million
Q4 2017

Feb 14, 2018

BUY
$37.77 - $47.75 $336,153 - $424,975
8,900 Added 65.65%
22,456 $1.04 Million
Q3 2017

Nov 14, 2017

BUY
$34.14 - $40.45 $462,801 - $548,340
13,556
13,556 $548,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $414M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.